Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-20

FDA Approved: FAMOTIDINE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter Healthcare Corporation's supplemental application for famotidine (ANDA075591), granting approval for the generic product under the supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

SUPPL AP for FAMOTIDINE (FAMOTIDINE)